Nuform, Southfield
US$ 25.49
gip/glp-1 agonist Potential Use of GLP-1 and Receptor Agonists for Respiratory Disorders: Where Are We at? The dual glucose-dependent insulinotropic polypeptide
Description
111 Health economics The economic implications of widespread GLP-1 RA use necessitate thorough evaluation
N Engl J Med 360(2):129139
People living with T2DM experience a two to four times increase in the incidence of cardiovascular disease (CVD) (Gregg et al
Several agents have shown cardiovascular outcome benefits in select populations, which guides therapy selection for people with existing atherosclerotic cardiovascular disease
[DOI] [PubMed] [Google Scholar] 77.Pach D, et al
doi: 10.1111/dom.15267
